109 related articles for article (PubMed ID: 16538501)
41. Overexpressed BAG3 is a potential therapeutic target in chronic lymphocytic leukemia.
Zhu H; Wu W; Fu Y; Shen W; Miao K; Hong M; Xu W; Young KH; Liu P; Li J
Ann Hematol; 2014 Mar; 93(3):425-35. PubMed ID: 23978946
[TBL] [Abstract][Full Text] [Related]
42. ZAP-70 and Bcl-2 expression in B lymphoblastic leukemia cells and hematogones.
Craig FE; Monaghan SA; Surti U; Swerdlow SH
Cytometry B Clin Cytom; 2012 Mar; 82(2):85-92. PubMed ID: 22031455
[TBL] [Abstract][Full Text] [Related]
43. Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers.
Pepper C; Lin TT; Pratt G; Hewamana S; Brennan P; Hiller L; Hills R; Ward R; Starczynski J; Austen B; Hooper L; Stankovic T; Fegan C
Blood; 2008 Nov; 112(9):3807-17. PubMed ID: 18599795
[TBL] [Abstract][Full Text] [Related]
44. Is the c-Cbl proto-oncogene involved in chronic lymphocytic leukemia?
Mankaï A; Eveillard JR; Buhé V; Le Ster K; Loisel S; Ghedira I; Youinou P; Berthou C; Bordron A
Ann N Y Acad Sci; 2007 Jun; 1107():193-205. PubMed ID: 17804547
[TBL] [Abstract][Full Text] [Related]
45. Adhesion of ZAP-70+ chronic lymphocytic leukemia cells to stromal cells is enhanced by cytokines and blocked by inhibitors of the PI3-kinase pathway.
Lafarge ST; Johnston JB; Gibson SB; Marshall AJ
Leuk Res; 2014 Jan; 38(1):109-15. PubMed ID: 23981382
[TBL] [Abstract][Full Text] [Related]
46. Cyclin-dependent kinase inhibitor Roscovitine induces apoptosis in chronic lymphocytic leukemia cells.
Hahntow IN; Schneller F; Oelsner M; Weick K; Ringshausen I; Fend F; Peschel C; Decker T
Leukemia; 2004 Apr; 18(4):747-55. PubMed ID: 14973497
[TBL] [Abstract][Full Text] [Related]
47. Recruitment of PKC-betaII to lipid rafts mediates apoptosis-resistance in chronic lymphocytic leukemia expressing ZAP-70.
zum Büschenfelde CM; Wagner M; Lutzny G; Oelsner M; Feuerstacke Y; Decker T; Bogner C; Peschel C; Ringshausen I
Leukemia; 2010 Jan; 24(1):141-52. PubMed ID: 19907441
[TBL] [Abstract][Full Text] [Related]
48. ZAP-70 mRNA expression provides clinically valuable information in early-stage chronic lymphocytic leukemia.
Reinoso-Martín C; Jantus-Lewintre E; Ballesteros CG; Campos CB; Ferrer JR; García-Conde J
Haematologica; 2008 Sep; 93(9):1422-4. PubMed ID: 18757853
[No Abstract] [Full Text] [Related]
49. Long intergenic non-coding RNA-p21 is associated with poor prognosis in chronic lymphocytic leukemia.
Abo Elwafa R; Abd Elrahman A; Ghallab O
Clin Transl Oncol; 2021 Jan; 23(1):92-99. PubMed ID: 32468342
[TBL] [Abstract][Full Text] [Related]
50. ZAP-70 expression and proliferative activity in chronic lymphocytic leukemia.
Šoljić V; Perak RB; Vukojević K; Saraga-Babić M; Bubalo P; Karan D; Todorović J; Batinić D
Leuk Lymphoma; 2013 Jun; 54(6):1171-6. PubMed ID: 23098292
[TBL] [Abstract][Full Text] [Related]
51. Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia.
Del Poeta G; Del Principe MI; Maurillo L; Rossi FM; Buccisano F; Ammatuna E; Simotti C; Zucchetto A; Catalano G; Bulian P; Bruno A; Venditti A; De Fabritiis P; Gattei V; Amadori S
Leuk Lymphoma; 2010 Jan; 51(1):95-106. PubMed ID: 20001236
[TBL] [Abstract][Full Text] [Related]
52. CD6 ligation modulates the Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM.
Osorio LM; De Santiago A; Aguilar-Santelises M; Mellstedt H; Jondal M
Blood; 1997 Apr; 89(8):2833-41. PubMed ID: 9108402
[TBL] [Abstract][Full Text] [Related]
53. Expression of ZAP-70 in patients with chronic lymphocytic leukemia may change significantly during the course of the disease.
Smolej L; Vroblova V; Novosad J
Int J Lab Hematol; 2008 Jun; 30(3):259-60; author reply 260. PubMed ID: 18479306
[No Abstract] [Full Text] [Related]
54. Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling.
Dielschneider RF; Xiao W; Yoon JY; Noh E; Banerji V; Li H; Marshall AJ; Johnston JB; Gibson SB
Cell Death Dis; 2014 Oct; 5(10):e1439. PubMed ID: 25275600
[TBL] [Abstract][Full Text] [Related]
55. ZAP-70 immunoreactivity is a prognostic marker of disease progression in chronic lymphocytic leukemia.
Vener C; Gianelli U; Cortelezzi A; Fracchiolla NS; Somalvico F; Savi F; Pasquini MC; Bosari S; Deliliers GL
Leuk Lymphoma; 2006 Feb; 47(2):245-51. PubMed ID: 16321853
[TBL] [Abstract][Full Text] [Related]
56. Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Moshynska O; Sankaran K; Pahwa P; Saxena A
J Natl Cancer Inst; 2004 May; 96(9):673-82. PubMed ID: 15126604
[TBL] [Abstract][Full Text] [Related]
57. ZAP-70 constitutively regulates gene expression and protein synthesis in chronic lymphocytic leukemia.
Chen J; Sathiaseelan V; Moore A; Tan S; Chilamakuri CSR; Roamio Franklin VN; Shahsavari A; Jakwerth CA; Hake SB; Warren AJ; Mohorianu I; D'Santos C; Ringshausen I
Blood; 2021 Jul; 137(26):3629-3640. PubMed ID: 33619528
[TBL] [Abstract][Full Text] [Related]
58. Low MCL-1 mRNA expression correlates with prolonged survival in B-cell chronic lymphocytic leukemia.
Véronèse L; Tournilhac O; Verrelle P; Davi F; Dighiero G; Chautard E; Veyrat-Masson R; Kwiatkowski F; Goumy C; Vago P; Travade P; Tchirkov A
Leukemia; 2008 Jun; 22(6):1291-3. PubMed ID: 18046444
[No Abstract] [Full Text] [Related]
59. Mcl-1 gene promoter insertions do not correlate with disease outcome, stage or VH gene mutation status in chronic lymphocytic leukaemia.
Tobin G; Skogsberg A; Thunberg U; Laurell A; Aleskog A; Merup M; Sundström C; Roos G; Nilsson K; Rosenquist R
Leukemia; 2005 May; 19(5):871-3. PubMed ID: 15759030
[No Abstract] [Full Text] [Related]
60. The gene expression response of chronic lymphocytic leukemia cells to IL-4 is specific, depends on ZAP-70 status and is differentially affected by an NFκB inhibitor.
Ruiz-Lafuente N; Alcaraz-García MJ; Sebastián-Ruiz S; Gómez-Espuch J; Funes C; Moraleda JM; García-Garay MC; Montes-Barqueros N; Minguela A; Álvarez-López MR; Parrado A
PLoS One; 2014; 9(10):e109533. PubMed ID: 25280001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
